FDA Approves First Phosphate Absorption Inhibitor for CKD

(MedPage Today) -- The FDA approved the first-in-class phosphate absorption inhibitor tenapanor (Xphozah) to reduce serum phosphorus in chronic kidney disease (CKD) patients on dialysis, developer Ardelyx announced on Tuesday. An oral drug, tenapanor...
Source: MedPage Today Public Health - Category: American Health Source Type: news